ABBVIE INC.

ABBV Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government

Chart provided by TradingView

$ABBV is featured in our Tom Carper strategy.

See All Strategies
Income
Balance Sheet
Cash Flow
ABBV Income Statement
ABBV Balance Sheet
ABBV Cash Flow
Congress Trading

Recent trades of ABBV by members of U.S. Congress

Politician Type Traded
John James House / R Sale $1,001 - $15,000 Sep. 04, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 02, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Apr. 10, 2024
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Apr. 03, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan. 23, 2024
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Jan. 19, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Dec. 08, 2023
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Nov. 20, 2023
John James House / R Purchase $1,001 - $15,000 Nov. 10, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Nov. 08, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct. 24, 2023
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Oct. 17, 2023
Robert J. Wittman House / R Sale $1,001 - $15,000 Sep. 28, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep. 26, 2023
Lois Frankel House / D Sale $1,001 - $15,000 Sep. 08, 2023
Lois Frankel House / D Purchase $1,001 - $15,000 Sep. 06, 2023
Lois Frankel House / D Purchase $1,001 - $15,000 Aug. 30, 2023
Michael C. Burgess House / R Sale $15,001 - $50,000 Aug. 14, 2023
Michael Guest House / R Purchase $1,001 - $15,000 Aug. 07, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Jul. 27, 2023
Daniel S. Goldman House / D Sale $1,001 - $15,000 Jul. 14, 2023
Daniel S. Goldman House / D Sale $50,001 - $100,000 Jul. 12, 2023
Michael C. Burgess House / R Purchase $15,001 - $50,000 Jul. 06, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Jun. 26, 2023
Zoe Lofgren House / D Sale $1,001 - $15,000 May. 26, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 May. 19, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Apr. 28, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Apr. 28, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Apr. 28, 2023
Daniel S. Goldman House / D Sale $15,001 - $50,000 Apr. 10, 2023
Tommy Tuberville Senate / R Sale (Partial) $1,001 - $15,000 Apr. 03, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Mar. 24, 2023
Daniel S. Goldman House / D Purchase $1,001 - $15,000 Mar. 07, 2023
Josh Gottheimer House / D Purchase $1,001 - $15,000 Mar. 06, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Feb. 21, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Feb. 07, 2023
Daniel S. Goldman House / D Purchase $1,001 - $15,000 Jan. 31, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Jan. 27, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Jan. 20, 2023
Kathy E. Manning House / D Purchase $1,001 - $15,000 Sep. 12, 2022
Dwight Evans House / D Purchase $1,001 - $15,000 Aug. 05, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Jul. 27, 2022
Kathy E. Manning House / D Sale $15,001 - $50,000 Jul. 27, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 27, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 15, 2022
Robert J. Wittman House / R Purchase $1,001 - $15,000 Jun. 16, 2022
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Mar. 30, 2022
Josh Gottheimer House / D Purchase $1,001 - $15,000 Mar. 17, 2022
John H. Rutherford House / R Sale $1,001 - $15,000 Mar. 16, 2022
Josh Gottheimer House / D Purchase $1,001 - $15,000 Mar. 08, 2022
ABBV Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ABBV Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ABBV Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by ABBV's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $1,280,000 Oct 21, 2024 Issue: Labor Issues/Antitrust/Workplace Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $580,000 Jul 22, 2024 Issue: Labor Issues/Antitrust/Workplace Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $1,590,000 Apr 22, 2024 Issue: Labor Issues/Antitrust/Workplace Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $830,000 Jan 22, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $750,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $600,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $1,500,000 Apr 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $970,000 Jan 20, 2023 Issue: Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $2,370,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $880,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $3,980,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $1,290,000 Jan 20, 2022 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $1,940,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $680,000 Jul 20, 2021 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $3,090,000 Apr 20, 2021 Issue: Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid Trade (domestic/foreign)
  • $650,000 Jan 20, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,430,000 Oct 20, 2020 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $670,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $2,980,000 Apr 20, 2020 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $970,000 Jan 21, 2020 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Budget/Appropriations
  • $1,790,000 Oct 21, 2019 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $900,000 Jul 22, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $2,680,000 Apr 22, 2019 Issue: Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues
  • $1,820,000 Jan 22, 2019 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $600,000 Oct 22, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $790,000 Jul 20, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $2,890,000 Apr 20, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,280,000 Jan 22, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Disaster Planning/Emergencies
  • $1,200,000 Oct 20, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $720,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Budget/Appropriations
  • $2,460,000 Apr 20, 2017 Issue: Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark
  • $1,040,000 Jan 20, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $2,610,000 Oct 28, 2016 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Budget/Appropriations
  • $1,920,000 Oct 20, 2016 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
  • $1,700,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Budget/Appropriations
  • $1,180,000 Jan 20, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,240,000 Oct 19, 2015 Issue: Health Issues Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Trade (domestic/foreign)
  • $930,000 Oct 19, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
  • $1,870,000 Oct 19, 2015 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Budget/Appropriations Trade (domestic/foreign)
  • $1,010,000 Jan 20, 2015 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
  • $1,600,000 Oct 17, 2014 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations Trade (domestic/foreign)
  • $880,000 Jul 21, 2014 Issue: Budget/Appropriations Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Copyright/Patent/Trademark
  • $1,450,000 Apr 21, 2014 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $600,000 Jan 21, 2014 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $630,000 Oct 21, 2013 Issue: Science/Technology Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Budget/Appropriations Health Issues
  • $1,180,000 Oct 21, 2013 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Budget/Appropriations Medicare/Medicaid
  • $770,000 Apr 22, 2013 Issue: Health Issues Budget/Appropriations Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Nov. 05, 2024
  • Patent Title: Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies Oct. 29, 2024
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Oct. 15, 2024
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Oct. 08, 2024
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Oct. 08, 2024
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Oct. 01, 2024
  • Patent Title: Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis Oct. 01, 2024
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Sep. 17, 2024
  • Patent Title: Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis Sep. 10, 2024
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Sep. 03, 2024
  • Patent Title: Container cap Jul. 09, 2024
  • Patent Title: Thiazolo[5,4-b]pyridine malt-1 inhibitors May. 28, 2024
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof May. 28, 2024
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof May. 28, 2024
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof May. 07, 2024
  • Patent Title: 1,3,4,7-tetrahydro-2h-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors Apr. 23, 2024
  • Patent Title: Modulators of the integrated stress pathway Mar. 26, 2024
  • Patent Title: Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases Feb. 13, 2024
  • Patent Title: Sleeve containers for packaging medicinal products Feb. 13, 2024
  • Patent Title: Carrying pack Dec. 12, 2023
  • Patent Title: Anti-amyloid beta antibodies and methods of using the same Oct. 31, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Oct. 24, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Oct. 17, 2023
  • Patent Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Oct. 17, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof Oct. 10, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof Oct. 10, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Oct. 03, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]- pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Oct. 03, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Sep. 26, 2023
  • Patent Title: Nicotinamide ripk1 inhibitors Sep. 26, 2023
  • Patent Title: Anti-egfr antibody-drug conjugates Sep. 19, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Aug. 08, 2023
  • Patent Title: Sleeve container Aug. 08, 2023
  • Patent Title: Sleeve container Aug. 08, 2023
  • Patent Title: Methods of treating heavy menstrual bleeding Jul. 25, 2023
  • Patent Title: Methods of treating heavy menstrual bleeding Jul. 04, 2023
  • Patent Title: Methods of administering elagolix Jul. 04, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Jun. 20, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof May. 30, 2023
  • Patent Title: Medicine container, method of assembling the container, and method of dispensing the medicine from the container May. 16, 2023
  • Patent Title: Anti-alpha-4-beta-7 antibodies May. 02, 2023
  • Patent Title: Anti-c-met antibody drug conjugates Apr. 25, 2023
  • Patent Title: Infusion pump Mar. 28, 2023
  • Patent Title: Methods of treating crohn's disease and ulcerative colitis Mar. 21, 2023
  • Patent Title: Methods of treating crohn's disease and ulcerative colitis Jan. 31, 2023
  • Patent Title: Prescription drug fulfillment system and method Jan. 03, 2023
  • Patent Title: Elagolix sodium compositions and processes Jan. 03, 2023
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1 carboxamide and solid state forms thereof Dec. 27, 2022
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Dec. 27, 2022
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Dec. 27, 2022
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of ABBV in WallStreetBets Daily Discussion

ABBV News

Recent insights relating to ABBV

CNBC Recommendations

Recent picks made for ABBV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ABBV

ABBV Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ABBV Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top